Drug Profile
Anti-L-selectin monoclonal antibody - Abgenix
Alternative Names: DREG 200 - AbgenixLatest Information Update: 25 Jul 2000
Price :
$50
*
At a glance
- Originator Abgenix
- Class
- Mechanism of Action L-selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 25 Jul 2000 Discontinued-Preclinical for Inflammation in USA (Unknown route)
- 06 May 1997 Preclinical development for Inflammation in USA (Unknown route)